Merck & Co.
Brian Maas, PharmD, is a Principal Scientist in the Quantitative Pharmacology and Pharmacometrics group at Merck. Brian holds a PharmD from the University of Florida, where he conducted research on evaluating the bioequivalence of inhaled drug products. He then completed a fellowship in pharmacometrics at the University of North Carolina and IQVIA, with a research focus on PK of HIV antiretrovirals and minimal PBPK modeling. In his current role, Brian serves as clinical pharmacology and pharmacometrics lead for several antiviral programs. His research interests are in infectious disease, pediatrics, and comparator modeling. Brian is a new member of ASCPT.